Tami Martin, R.N.

2020

In 2020, Tami Martin, R.N. earned a total compensation of $804.6K as Senior Vice President, Regulatory Affairs at Supernus Pharmaceuticals, a 8% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$131,200
Option Awards$309,438
Salary$326,401
Other$37,598
Total$804,637

RN received $326.4K in salary, accounting for 41% of the total pay in 2020.

RN also received $131.2K in non-equity incentive plan, $309.4K in option awards and $37.6K in other compensation.

Rankings

In 2020, Tami Martin, R.N.'s compensation ranked 9,481st out of 13,090 executives tracked by ExecPay. In other words, RN earned more than 27.6% of executives.

ClassificationRankingPercentile
All
9,481
out of 13,090
28th
Division
Manufacturing
4,061
out of 5,618
28th
Major group
Chemicals And Allied Products
1,653
out of 2,251
27th
Industry group
Drugs
1,449
out of 1,951
26th
Industry
Pharmaceutical Preparations
1,066
out of 1,456
27th

Pay ratio

Tami Martin, R.N.'s Pay$804,637
Median Employee's Pay$148,804
Pay Ratio

5

to 1

In 2020, the annual total compensation of Tami Martin, R.N. was $804,637.

The annual total compensation of the median employee at Supernus Pharmaceuticals was $148,804.

The ratio of Tami Martin, R.N.'s pay to the pay of median employee was therefore 5 to one.

Source: SEC filing on April 30, 2021.

RN's colleagues

We found five more compensation records of executives who worked with Tami Martin, R.N. at Supernus Pharmaceuticals in 2020.

2020

Jack Khattar

Supernus Pharmaceuticals

Chief Executive Officer

2020

James Kelly

Supernus Pharmaceuticals

Chief Financial Officer

2020

Stefan Schwabe

Supernus Pharmaceuticals

Chief Medical Officer

2020

Gregory Patrick

Supernus Pharmaceuticals

Chief Financial Officer

2020

Padmanabh Bhatt

Supernus Pharmaceuticals

Chief Scientific Officer

News

You may also like